These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cross-sex hormone administration changes pain in transsexual women and men. Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410 [TBL] [Abstract][Full Text] [Related]
8. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects. Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946 [TBL] [Abstract][Full Text] [Related]
9. Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals. Ott J; Aust S; Promberger R; Huber JC; Kaufmann U J Sex Med; 2011 Aug; 8(8):2361-9. PubMed ID: 21595834 [TBL] [Abstract][Full Text] [Related]
10. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity. Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918 [TBL] [Abstract][Full Text] [Related]
11. Effects of long-term androgen administration on breast tissue of female-to-male transsexuals. Slagter MH; Gooren LJ; Scorilas A; Petraki CD; Diamandis EP J Histochem Cytochem; 2006 Aug; 54(8):905-10. PubMed ID: 16618941 [TBL] [Abstract][Full Text] [Related]
12. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. Mueller A; Gooren L Eur J Endocrinol; 2008 Sep; 159(3):197-202. PubMed ID: 18567667 [TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures. Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249 [TBL] [Abstract][Full Text] [Related]
14. Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Elbers JM; de Jong S; Teerlink T; Asscheman H; Seidell JC; Gooren LJ Metabolism; 1999 Nov; 48(11):1371-7. PubMed ID: 10582544 [TBL] [Abstract][Full Text] [Related]
15. Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Mueller A; Zollver H; Kronawitter D; Oppelt PG; Claassen T; Hoffmann I; Beckmann MW; Dittrich R Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):95-100. PubMed ID: 20625973 [TBL] [Abstract][Full Text] [Related]
16. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351 [TBL] [Abstract][Full Text] [Related]
17. [Morbidity in transsexual patients with cross-gender hormone self-treatment]. Becerra Fernández A; de Luis Román DA; Piédrola Maroto G Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171 [TBL] [Abstract][Full Text] [Related]
18. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects. Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863 [TBL] [Abstract][Full Text] [Related]
19. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening. Fledderus AC; Gout HA; Ogilvie AC; van Loenen DKG Breast; 2020 Oct; 53():92-100. PubMed ID: 32679529 [TBL] [Abstract][Full Text] [Related]
20. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness. Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]